Search PubMed⌕ Search

Biomedical subjects

R Kumar

Publications and source records attributed to R Kumar.

At least 1,549 records · Page 86Linked to original sources

Dinitrochlorobenzene contact sensitization in pulmonary tuberculosis.

Skin sensitization with DNCB was carried out in forty-five untreated, 106 "on treatment" and fifteen fully treated patients with pulmonary tuberculosis along with fifty-five controls. Mantoux test with PPD was also carried out simultaneously. All the normal controls could be sensitized to DNCB and the degree of sensitization was 4+ in majority of the subjects. In contrast, in untreated patients only eighteen could be sensitized to DNCB and the degree of sensitivity did not reach 4+ in any patient. Similarly, fifty-five patients could not be sensitized with DNCB in the group of 106 subjects who were still suffering from active disease and were on therapy and none gave a 4+ response. The difference in the proportion of subjects who could be sensitized to DNCB in these two patient groups was significantly less in comparison to controls. Among fifteen patients who were fully treated and did not have active disease thirteeen could be sensitized with DNCB, but the degree of response was again found to be less than the controls. All the patients as well as the controls gave a high proportion of Mantoux positivity. These findings indicate that there is a subtle degree of immunodeficiency in pulmonary tuberculosis which improves simultaneously with the clinical improvement.

Adolescent↗

Early recovery of exocrine pancreatic function in adult protein-calorie malnutrition.

Nine adult patients with protein-calorie malnutrition underwent a pancreozymin-secretin test of exocrine pancreatic function and then were treated with a high protein diet. Studies of pancreatic function were repeated at 2 weeks and again at 6 weeks following institution of a high protein diet. There was substantial recovery in exocrine pancreatic function after only 2 weeks of dietary therapy.

Adult↗

Immunological study of typhoid: immunoglobulins, C3, antibodies, and leukocyte migration inhibition in patients with typhoid fever and TAB-vaccinated individuals.

The development of humoral and cell-mediated immune responses to Salmonella typhi antigens and immunoglobulin and C(3) levels were determined in patients suffering from typhoid fever, TAB-vaccinated individuals, and appropriate controls. In 45 patients with typhoid, a significant elevation of immunoglobulin M (IgM) level was noted from the first week of illness onwards. Eighteen TAB-vaccinated persons also showed a significant elevation of IgM levels. In typhoid sera, the anti-O and anti-H antibodies were mostly 2-mercaptoethanol (2-ME) sensitive. The rise of IgM level correlated well with the 2-ME-sensitive anti-O and anti-H antibodies seen in typhoid patients. The anti-O antibodies in the TAB-vaccinated group were almost entirely 2-ME sensitive, but both 2-ME-sensitive and -resistant anti-H antibodies were detected in the TAB group. A marked increas in C(3) level was also noted in patients with typhoid. The cell-mediated immunity (CMI), as measured by leukocyte migration inhibition tests, was demonstrable in 15 of 22 patients with typhoid. On the other hand, only 8 of the 20 normal subjects, 5 of the 16 fever control cases, and 6 of the 18 TAB-vaccinated individuals gave a positive CMI. The latter three groups were comparable with each other but were significantly different from the typhoid patients. It was concluded that TAB-vaccination did not induce CMI even though it induced the development of antibodies, the latter being comparable with those of the patients with typhoid. The significance of these findings is discussed.

Agglutination Tests↗